Antitumor activity and expression profiles of genes induced by sulforaphane in human melanoma cells

Paola Arcidiacono1,2, Francesco Ragonese1, Anna Stabile3

  • 1Department of Life Sciences, Imperial College London, London SW7 2AZ, United KingdomDepartment of Experimental Medicine, University of Perugia, Piazza Lucio Severi, 06132, Perugia, Italy.

Abstract

Insights

Sulforaphane (SFN) effectively reduced melanoma cell viability and proliferation, inducing apoptosis and cell cycle arrest. This natural compound shows promise as a cancer prevention agent by targeting complex mechanisms in melanoma progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Human melanoma is an aggressive cancer characterized by resistance to apoptosis, proliferation, and survival mechanisms.
  • Sulforaphane (SFN), a compound from cruciferous vegetables, has shown roles in various cancer types, but its specific cytotoxic mechanisms in melanoma are not fully understood.

Purpose of the Study:

  • To investigate the molecular mechanisms and gene expression profiles induced by SFN in human melanoma cells.
  • To determine the effects of SFN on melanoma cell viability, proliferation, cell cycle, migration, invasion, and apoptosis.

Main Methods:

  • Utilized human melanoma cell lines (A375, 501MEL) and normal human epidermal melanocytes (HEMa).
  • Assessed cell viability, proliferation, cell cycle, migration, and invasion.
  • Analyzed protein expression and phosphorylation of Akt and p53.
  • Performed RNA sequencing (RNA-seq) on A375 cells treated with SFN.

Main Results:

  • SFN significantly decreased melanoma cell viability and proliferation, inducing G2/M cell cycle arrest and apoptosis via caspase activation.
  • SFN inhibited melanoma cell migration and invasion, while normal melanocytes remained unaffected.
  • Transcriptomic analysis revealed SFN modulates genes involved in stress response, apoptosis, and metabolism, upregulating pro-apoptotic genes (e.g., p53, BAX) and cell cycle inhibitors (e.g., EGR1, CDKN1A), while also inhibiting genotoxicity via stress-inducible proteins (e.g., HMOX1, SOD1).

Conclusions:

  • SFN exhibits potent cytotoxicity in melanoma through multifaceted and concurrent mechanisms.
  • These findings highlight SFN's potential as a promising agent for cancer prevention in melanoma.